Switch to:
More From Other Websites
Why Stratasys, Ltd. (SSYS), Arconic Inc (ARNC) and Seattle Genetics, Inc. (SGEN) Are 3 of Today’s... Jun 26 2017
Biotech Rally Stumbles As These Small Caps Pull Back Jun 26 2017
Seattle Genetics: A Disappointing Study…Or Was It? Jun 26 2017
Why Shares of Seattle Genetics, Inc. Got Whacked Today Jun 26 2017
Seattle Genetics slumps as cancer drug data fails to impress Jun 26 2017
Story Stocks from Briefing.com Jun 26 2017
J.P. Morgan Gives Thoughts on Seattle Genetics, Inc. (SGEN) Following Phase 3 Results Jun 26 2017
UPDATE 1-Seattle Genetics, Takeda lymphoma drug success fails to impress investors Jun 26 2017
Biotech Movers: Seattle Genetics, FibroGen, Sangamo Jun 26 2017
Seattle Genetics, Takeda lymphoma drug succeeds late-stage trial Jun 26 2017
Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial... Jun 26 2017
Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma Jun 26 2017
Seattle Genetics Plunges After Issuing Stage 3 Trial Results Jun 26 2017
Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug Jun 21 2017
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt Jun 21 2017
Adcetris-Opdivo Combination for Classical Hodgkin Lymphoma Jun 21 2017
Updates on the Adcetris and Opdivo Combination Jun 20 2017
Seattle Genetics Halts Phase III Study on Leukemia Drug Jun 20 2017
Seattle Genetics Submits Supplemental Biologics License Application to FDA for ADCETRIS®... Jun 20 2017
Apple, PerkinElmer rise; EQT, Seattle Genetics fall Jun 19 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK